ArticleFrontiers in neurology2019
Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.
Abstract read
In one paragraph
Article in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinion.Journal of neurology · 2025Review
- Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies.Neurology(R) neuroimmunology & neuroinflammation · 2023Review
- Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspective.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023Review
- Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World Study.International journal of environmental research and public health · 2022Article
- Article
- Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study.BMC neurology · 2021Observational
- "If You Can't Control the Wind, Adjust Your Sail": Tips for Post-Pandemic Benefit Finding from Young Adults Living with Multiple Sclerosis. A Qualitative Study.International journal of environmental research and public health · 2021Article
- Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives.Patient preference and adherence · 2021Review
- Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy.PloS one · 2020Article
- A realist review of advance care planning for people with multiple sclerosis and their families.PloS one · 2020Review
- Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group Study.Frontiers in neurology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
45 authors.
Alessandra SolariUnit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Ambra Mara GiovannettiUnit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Andrea GiordanoUnit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Carla TortorellaDepartment of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
Valentina Torri ClericiMultiple Sclerosis Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Giampaolo BrichettoRehabilitation Centre, Italian Multiple Sclerosis Society, Genoa, Italy.
Franco GranellaNeurosciences Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Alessandra LugaresiUOSI Riabilitazione Sclerosi Multipla, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Francesco PattiSezione Neuroscienze, Dipartimento di Scienze Mediche e Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", Università di Catania, Catania, Italy.
Marco SalvettiIRCCS Neuromed, Pozzilli, Italy.
Ilaria PesciUnità di Neurologia, Centro Sclerosi Multipla, Ospedale di Vaio, Fidenza, Italy.
Eugenio PucciUOC Neurologia, Ospedale "A. Murri", ASUR Marche-AV4, Fermo, Italy.
Diego CentonzeIRCCS Neuromed, Pozzilli, Italy.
Maura Chiara DanniClinica Neurologica, Università Politecnica delle Marche, Ancona, Italy.
Simona BonavitaII Clinica Neurologica, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.
Diana FerraroDepartment of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy.
Antonio GalloI Clinica Neurologica, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.
Alberto GajofattoDipartimento di Neuroscienze, Biomedicina e Movimento, Università di Verona, Verona, Italy.
Viviana NocitiIstituto di Neurologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
Luigi GrimaldiUOC Neurologia e Centro Regionale SM, Fondazione Istituto "G. Giglio", Cefalù, Italy.
Monica GrobberioLaboratory of Clinical Neuropsychology, Department of Neurology and Psychology, ASST Lariana, Como, Italy.
Roberta LanzilloNeurosciences, Reproductive and Odontostomatological Sciences Department, Federico II University of Naples, Naples, Italy.
Rachele Di GiovanniRehabilitation Unit, Mons. L. Novarese Hospital, Moncrivello, Italy.
Silvia GregoriUOC Neurologia, Ospedale San Camillo de Lellis, Rieti, Italy.
Alessia ManniDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, Aldo Moro University of Bari, Bari, Italy.
Erika PietrolongoDepartment of Neuroscience, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy.
Sarah BertagnoliItalian Multiple Sclerosis Society, Mantua, Italy.
Marco RonzoniCentro Sclerosi Multipla, Ospedale "G. Salvini"-ASST Rhodense, Garbagnate Milanese, Italy.
Laura CompagnucciClinica Neurologica, Università Politecnica delle Marche, Ancona, Italy.
Roberta FantozziIRCCS Neuromed, Pozzilli, Italy.
Beatrice AllegriUnità di Neurologia, Centro Sclerosi Multipla, Ospedale di Vaio, Fidenza, Italy.
Sebastiano ArenaSezione Neuroscienze, Dipartimento di Scienze Mediche e Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", Università di Catania, Catania, Italy.
Maria Chiara BuscarinuDepartment of Neurosciences, Mental Health, and Sensory Organs (NESMOS), Sapienza University of Rome, Rome, Italy.
Loredana SabattiniUOSI Riabilitazione Sclerosi Multipla, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Maria Esmeralda QuartuccioDepartment of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
Elena TsantesNeurosciences Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Paolo ConfaloneriMultiple Sclerosis Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Andrea TacchinoScientific Research Area, Italian Multiple Sclerosis Foundation, Genoa, Italy.
Insa SchiffmannInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Anne Christin RahnInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ingo KleiterKempfenhausen Centre for Treatment of Multiple Sclerosis, Marianne-Strauß-Klinik, Berg, Germany.
Michele Messmer UccelliItalian Multiple Sclerosis Society Research Foundation (FISM), Genoa, Italy.
Anna BarabaschInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Christoph HeesenInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
The ManTra ProjectUnit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
conversionmultiple sclerosisonline surveypatient needspatient-physician communicationsecondary progressive multiple sclerosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.